Literature DB >> 12001050

Infectivity of a Cryptosporidium parvum isolate of cervine origin for healthy adults and interferon-gamma knockout mice.

Pablo C Okhuysen1, Stephen M Rich, Cynthia L Chappell, Kevin A Grimes, Giovanni Widmer, Xiaochuan Feng, Saul Tzipori.   

Abstract

The infectivity of a Cryptosporidium parvum isolate of cervine origin (type 2, Moredun) propagated in calves was investigated simultaneously in healthy adult human volunteers and in interferon-gamma knockout (GKO) mice. After exposure to 100-3000 oocysts, 16 volunteers recorded, for a duration of 6 weeks, the number and form of stools that they passed and any symptoms that they experienced. Oocyst excretion was assessed by enzyme-linked immunosorbent assay and direct immunofluorescence assay. Eleven subjects (69%) became ill, and 8 subjects (50%) shed oocysts in stool. The median duration of illness was 169 h, and the median number of unformed stools passed was 24. The duration and intensity of symptoms were more severe than were those associated with previously studied isolates. The median infectious dose was estimated to be 300 oocysts for humans and 1 oocyst for the GKO mouse model. The Moredun isolate was more pathogenic than the reference GCH-1 isolate. The GKO mouse model of cryptosporidiosis is useful for discerning isolate-specific differences in pathogenicity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12001050     DOI: 10.1086/340132

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  29 in total

Review 1.  Cryptosporidiosis: environmental, therapeutic, and preventive challenges.

Authors:  S Collinet-Adler; H D Ward
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-06-04       Impact factor: 3.267

2.  Infection with Cryptosporidium hominis provides incomplete protection of the host against Cryptosporidium parvum.

Authors:  Abhineet Sheoran; Anthony Wiffin; Giovanni Widmer; Pradeep Singh; Saul Tzipori
Journal:  J Infect Dis       Date:  2012-01-25       Impact factor: 5.226

3.  Cryptosporidium meleagridis: infectivity in healthy adult volunteers.

Authors:  Cynthia L Chappell; Pablo C Okhuysen; Rebecca C Langer-Curry; Donna E Akiyoshi; Giovanni Widmer; Saul Tzipori
Journal:  Am J Trop Med Hyg       Date:  2011-08       Impact factor: 2.345

4.  MyD88-dependent pathways mediate resistance to Cryptosporidium parvum infection in mice.

Authors:  K A Rogers; A B Rogers; B A Leav; A Sanchez; E Vannier; S Uematsu; S Akira; D Golenbock; H D Ward
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

5.  Cryptosporidium muris: infectivity and illness in healthy adult volunteers.

Authors:  Cynthia L Chappell; Pablo C Okhuysen; Rebecca C Langer-Curry; Philip J Lupo; Giovanni Widmer; Saul Tzipori
Journal:  Am J Trop Med Hyg       Date:  2014-10-13       Impact factor: 2.345

6.  Diverse single-amino-acid repeat profiles in the genus Cryptosporidium.

Authors:  Giovanni Widmer
Journal:  Parasitology       Date:  2018-02-12       Impact factor: 3.234

7.  A rapid and specific method for the detection of indole in complex biological samples.

Authors:  Charles Darkoh; Cynthia Chappell; Christopher Gonzales; Pablo Okhuysen
Journal:  Appl Environ Microbiol       Date:  2015-09-18       Impact factor: 4.792

8.  Host cell tropism underlies species restriction of human and bovine Cryptosporidium parvum genotypes.

Authors:  Amna Hashim; Marguerite Clyne; Grace Mulcahy; Donna Akiyoshi; Rachel Chalmers; Billy Bourke
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

9.  Rapid displacement of Cryptosporidium parvum type 1 by type 2 in mixed infections in piglets.

Authors:  Donna E Akiyoshi; Siobhan Mor; Saul Tzipori
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

10.  Cryptosporidium hominis infection of the human respiratory tract.

Authors:  Rubén Mercado; Gregory A Buck; Patricio A Manque; Luiz Shozo Ozaki
Journal:  Emerg Infect Dis       Date:  2007-03       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.